Literature DB >> 15803397

Determining the optimal size of small molecule mixtures for high throughput NMR screening.

Kelly A Mercier1, Robert Powers.   

Abstract

High-throughput screening (HTS) using NMR spectroscopy has become a common component of the drug discovery effort and is widely used throughout the pharmaceutical industry. NMR provides additional information about the nature of small molecule-protein interactions compared to traditional HTS methods. In order to achieve comparable efficiency, small molecules are often screened as mixtures in NMR-based assays. Nevertheless, an analysis of the efficiency of mixtures and a corresponding determination of the optimum mixture size (OMS) that minimizes the amount of material and instrumentation time required for an NMR screen has been lacking. A model for calculating OMS based on the application of the hypergeometric distribution function to determine the probability of a "hit" for various mixture sizes and hit rates is presented. An alternative method for the deconvolution of large screening mixtures is also discussed. These methods have been applied in a high-throughput NMR screening assay using a small, directed library.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15803397     DOI: 10.1007/s10858-005-0948-4

Source DB:  PubMed          Journal:  J Biomol NMR        ISSN: 0925-2738            Impact factor:   2.835


  50 in total

Review 1.  NMR techniques for characterization of ligand binding: utility for lead generation and optimization in drug discovery.

Authors:  J M Moore
Journal:  Biopolymers       Date:  1999       Impact factor: 2.505

2.  Ruminations regarding the design of small mixtures for biological testing.

Authors:  J Teixido; E L Michelotti; C M Tice
Journal:  J Comb Chem       Date:  2000 Nov-Dec

Review 3.  Chemoinformatics - similarity and diversity in chemical libraries.

Authors:  P Willett
Journal:  Curr Opin Biotechnol       Date:  2000-02       Impact factor: 9.740

4.  Drug-like index: a new approach to measure drug-like compounds and their diversity.

Authors:  J Xu; J Stevenson
Journal:  J Chem Inf Comput Sci       Date:  2000 Sep-Oct

Review 5.  NMR in the acceleration of drug discovery.

Authors:  D S Sem; M Pellecchia
Journal:  Curr Opin Drug Discov Devel       Date:  2001-07

6.  A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening.

Authors:  Susan L McGovern; Emilia Caselli; Nikolaus Grigorieff; Brian K Shoichet
Journal:  J Med Chem       Date:  2002-04-11       Impact factor: 7.446

Review 7.  Applications of SHAPES screening in drug discovery.

Authors:  Christopher A Lepre; Jeffrey Peng; Jasna Fejzo; Norzehan Abdul-Manan; Jennifer Pocas; Marc Jacobs; Xiaoling Xie; Jonathan M Moore
Journal:  Comb Chem High Throughput Screen       Date:  2002-12       Impact factor: 1.339

Review 8.  NMR methods for the determination of protein-ligand dissociation constants.

Authors:  Lee Fielding
Journal:  Curr Top Med Chem       Date:  2003       Impact factor: 3.295

9.  Screening mixtures for biological activity by NMR.

Authors:  B Meyer; T Weimar; T Peters
Journal:  Eur J Biochem       Date:  1997-06-15

10.  MS/NMR: a structure-based approach for discovering protein ligands and for drug design by coupling size exclusion chromatography, mass spectrometry, and nuclear magnetic resonance spectroscopy.

Authors:  F J Moy; K Haraki; D Mobilio; G Walker; R Powers; K Tabei; H Tong; M M Siegel
Journal:  Anal Chem       Date:  2001-02-01       Impact factor: 6.986

View more
  10 in total

1.  FAST-NMR: functional annotation screening technology using NMR spectroscopy.

Authors:  Kelly A Mercier; Michael Baran; Viswanathan Ramanathan; Peter Revesz; Rong Xiao; Gaetano T Montelione; Robert Powers
Journal:  J Am Chem Soc       Date:  2006-11-29       Impact factor: 15.419

Review 2.  The application of FAST-NMR for the identification of novel drug discovery targets.

Authors:  Robert Powers; Kelly A Mercier; Jennifer C Copeland
Journal:  Drug Discov Today       Date:  2008-02       Impact factor: 7.851

Review 3.  Application of NMR and molecular docking in structure-based drug discovery.

Authors:  Jaime L Stark; Robert Powers
Journal:  Top Curr Chem       Date:  2012

4.  Drug screening strategy for human membrane proteins: from NMR protein backbone structure to in silica- and NMR-screened hits.

Authors:  Steffen Lindert; Innokentiy Maslennikov; Ellis J C Chiu; Levi C Pierce; J Andrew McCammon; Senyon Choe
Journal:  Biochem Biophys Res Commun       Date:  2014-02-10       Impact factor: 3.575

Review 5.  High-field solution NMR spectroscopy as a tool for assessing protein interactions with small molecule ligands.

Authors:  Andria L Skinner; Jennifer S Laurence
Journal:  J Pharm Sci       Date:  2008-11       Impact factor: 3.534

6.  NMRmix: A Tool for the Optimization of Compound Mixtures in 1D (1)H NMR Ligand Affinity Screens.

Authors:  Jaime L Stark; Hamid R Eghbalnia; Woonghee Lee; William M Westler; John L Markley
Journal:  J Proteome Res       Date:  2016-03-23       Impact factor: 4.466

7.  Fragment-Based Drug Discovery by NMR. Where Are the Successes and Where can It Be Improved?

Authors:  Luca G Mureddu; Geerten W Vuister
Journal:  Front Mol Biosci       Date:  2022-02-18

8.  Multiplexing siRNAs to compress RNAi-based screen size in human cells.

Authors:  Scott E Martin; Tamara L Jones; Cheryl L Thomas; Philip L Lorenzi; Dac A Nguyen; Timothy Runfola; Michele Gunsior; John N Weinstein; Paul K Goldsmith; Eric Lader; Konrad Huppi; Natasha J Caplen
Journal:  Nucleic Acids Res       Date:  2007-03-28       Impact factor: 16.971

9.  poolHiTS: a shifted transversal design based pooling strategy for high-throughput drug screening.

Authors:  Raghunandan M Kainkaryam; Peter J Woolf
Journal:  BMC Bioinformatics       Date:  2008-05-30       Impact factor: 3.169

10.  Structure and function of human DnaJ homologue subfamily a member 1 (DNAJA1) and its relationship to pancreatic cancer.

Authors:  Jaime L Stark; Kamiya Mehla; Nina Chaika; Thomas B Acton; Rong Xiao; Pankaj K Singh; Gaetano T Montelione; Robert Powers
Journal:  Biochemistry       Date:  2014-02-19       Impact factor: 3.162

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.